gmpnews-1-2017-annonceRussian Magazine for the Leaders of Pharmaceutical Industry
Subscribe for free!
(In Russian)

TOP News

Vialek Book Banner

Rostec, Pharmstandard and Kedrion established a joint venture

The National Immunobiological Company (part of Rostec State Corporation), Pharmstandard and Kedrion Biopharma (Italy) signed an agreement to establish Kirov Plasma, a joint-stock company. The company ...

Altai Biopharmaceutical Cluster shipped products worth 20 bln rubles in 2016

In the Altai Krai, the development of pharmaceutical industry and biotechnology is aimed at ensuring import substitution of medicinal products by their Russian-made analogs. According to the Altay ...

A pharmaceutical cluster is established in Moscow region

The agreement was signed by IBPM of RAS, IPCP of RAS, ITEB of RAS, IFPB of RAS, BIBC of RAS, Hospital of ChSC of RAS, Hospital of PSC of RAS, Test Pushchino LLC, and Pre-Clinical Trials LLC. The agree...

Indian ministry projects an e-portal to track sale of medicines

In order to ensure that drugs meet quality standards, Indian union health ministry could create a digital platform to track and regulate their sale in the country. A notice posted on the ministry's we...

Novartis drug failed the clinical trial

Novartis reported that its Phase III RELAX-AHF-2 clinical trial of RLX030 (serelaxin) in patients with acute heart failure failed to meet its primary endpoints. Its primary endpoint was reduction ...

European Commission approved first biosimilar Adalimumab

Amgen announced that the European Commission (EC) has granted marketing authorization for AMGEVITA (biosimilar adalimumab) in all available indications. AMGEVITA is authorized for the treatment of cer...

Injectable medicines market will reach $624.50 bln by 2021

According to MarketsandMarkets report the global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 Billion by 2021 from USD 362.38 Billion in 2016, at a CAGR of 11.5...

Subscribe to GMP news Newsletter!

Pharmcontract Banner


National producers entered the market with nearly a dozen of biosimilars of expensive medicines

Denis Manturov
Denis Manturov told the correspondent of "Expert" magazine how the Ministry for Industry & Trade continues to work towards technical upgrading of the Russian industry, about current progress in th...

The long and expensive process to enter the international market

Nikolai Yemelianov - Niarmedic Plus
What is the difference between the native antiviral drugs and imported ones and what is necessary for their entry into foreign markets, described the head of the Department of medical research and inf...

Modern Russian enterprises are not inferior in terms of quality to the foreign facilities

The 19th International Exhibition of equipment, raw materials and technologies for pharmaceutical production – Pharmtech & Ingredients 2016 – was held on November 22-25, 2016.   On the first da...

Subscribe to GMP news Newsletter!